Notch2 Inhibition and Kidney Cyst Growth in Autosomal Dominant Polycystic Kidney Disease
- PMID: 39745791
- PMCID: PMC12059103
- DOI: 10.1681/ASN.0000000592
Notch2 Inhibition and Kidney Cyst Growth in Autosomal Dominant Polycystic Kidney Disease
Abstract
Key Points:
Notch2 activation promotes kidney cyst growth.
Silencing Notch2 ameliorated cyst growth in mice with autosomal dominant polycystic kidney disease.
Background: Notch signaling, a conserved mechanism of cell-to-cell communication, plays a crucial role in regulating cellular processes, such as proliferation and differentiation, in a context-dependent manner. However, the specific contribution of Notch signaling to the progression of polycystic kidney disease (PKD) remains unclear.
Methods: We investigated the changes in Notch signaling activity (Notch1–4) in the kidneys of patients with autosomal dominant PKD (ADPKD) and two ADPKD mouse models (early and late onset). Multiple genetic and pharmacologic approaches were used to explore Notch2 signaling during kidney cyst formation in PKD.
Results: Notch2 expression was significantly increased in the kidney tissues of patients with ADPKD and ADPKD mice. Targeted expression of Notch2 intracellular domain in renal epithelial cells resulted in cyst formation and kidney failure in neonatal and adult mice. Mechanistically, Notch2/Hey2 signaling promoted renal epithelial cell proliferation by driving the expression of the E26 transformation–specific homologous factor (Ehf). Depletion of Ehf delayed Notch2 intracellular domain overexpression–induced cyst formation and kidney failure in mice. A gain-of-function mutation in exon 34 of NOTCH2 (c.6426dupT), which caused PKD in patients with Hajdu–Cheney syndrome, accelerated cell growth in cultured human renal epithelial cells by activating HEY2/EHF signaling. Finally, ablation of Notch2 or treatment of a kidney-targeting nanoparticle carrying the liposome/Notch2–small interfering RNA complex, significantly suppressed kidney cyst growth in early-onset ADPKD mice.
Conclusions: Notch2 signaling promoted kidney cyst growth, partially by upregulating Ehf expression.
Keywords: polycystic kidney disease.
Conflict of interest statement
Disclosure forms, as provided by each author, are available with the online version of the article at
Similar articles
-
Early treatment with 2-deoxy-d-glucose reduces proliferative proteins in the kidney and slows cyst growth in a hypomorphic Pkd1 mouse model of autosomal dominant polycystic kidney disease (PKD).Cell Signal. 2024 Nov;123:111351. doi: 10.1016/j.cellsig.2024.111351. Epub 2024 Aug 17. Cell Signal. 2024. PMID: 39159908
-
nnUNet for Automatic Kidney and Cyst Segmentation in Autosomal Dominant Polycystic Kidney Disease.Curr Med Imaging. 2024;20:e15734056272767. doi: 10.2174/0115734056272767231130110017. Curr Med Imaging. 2024. PMID: 38389364
-
Dnajb11-Kidney Disease Develops from Reduced Polycystin-1 Dosage but not Unfolded Protein Response in Mice.J Am Soc Nephrol. 2023 Sep 1;34(9):1521-1534. doi: 10.1681/ASN.0000000000000164. Epub 2023 Jun 19. J Am Soc Nephrol. 2023. PMID: 37332102 Free PMC article.
-
Empowering women at the heart of autosomal dominant polycystic kidney disease: Addressing unique challenges gender-sensitive approach.Womens Health (Lond). 2025 Jan-Dec;21:17455057251345944. doi: 10.1177/17455057251345944. Epub 2025 Jul 19. Womens Health (Lond). 2025. PMID: 40682339 Free PMC article. Review.
-
Management of renal cyst infection in patients with autosomal dominant polycystic kidney disease: a systematic review.Nephrol Dial Transplant. 2017 Jan 1;32(1):144-150. doi: 10.1093/ndt/gfv452. Nephrol Dial Transplant. 2017. PMID: 26908766
Cited by
-
Mechanistic Insights into the Pathogenesis of Polycystic Kidney Disease.Cells. 2025 Aug 5;14(15):1203. doi: 10.3390/cells14151203. Cells. 2025. PMID: 40801635 Free PMC article. Review.
References
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous